To compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (ICHD-II criteria) enrolled in a multicentre, randomized, double-blind, crossover study. Conclusions Frovatriptan was as effective as almotriptan in the immediate treatment of menstrually related migraine attacks. However, it showed a more favorable sustained effect, as shown by a lower rate of migraine recurrence.
Efficacy of frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, crossover, multicentre Italian, comparative study / M., B., M. A., G., C., L., P., M., D., M., B., P., L., S., Pini, L.A., G., S., P., S., G., Z., S., O., M. D., F., B., F., F., B.. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - STAMPA. - 13:(2012), pp. S48-S48. (XXVI Nation Congress of the Italian Society for the Study of Headaches. Pharmacological therapies and beyond Modena 26-28 October 2012).
Efficacy of frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, crossover, multicentre Italian, comparative study
PINI, Luigi Alberto;
2012
Abstract
To compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (ICHD-II criteria) enrolled in a multicentre, randomized, double-blind, crossover study. Conclusions Frovatriptan was as effective as almotriptan in the immediate treatment of menstrually related migraine attacks. However, it showed a more favorable sustained effect, as shown by a lower rate of migraine recurrence.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
